Connection

Xing-Lou Yang to Vero Cells

Back to Details
This is a "connection" page, showing publications Xing-Lou Yang has written about Vero Cells.
Xing-Lou Yang
Connection Strength
0.120
Vero Cells
  1. Identification of potent human neutralizing antibodies against SARS-CoV-2 implications for development of therapeutics and prophylactics. Nat Commun. 2021 08 09; 12(1):4887.
    View in: PubMed
    Score: 0.017
  2. The SARS-CoV-2 subgenome landscape and its novel regulatory features. Mol Cell. 2021 05 20; 81(10):2135-2147.e5.
    View in: PubMed
    Score: 0.017
  3. Gemcitabine, lycorine and oxysophoridine inhibit novel coronavirus (SARS-CoV-2) in cell culture. Emerg Microbes Infect. 2020 Dec; 9(1):1170-1173.
    View in: PubMed
    Score: 0.016
  4. Comparative Antiviral Efficacy of Viral Protease Inhibitors against the Novel SARS-CoV-2 In Vitro. Virol Sin. 2020 Dec; 35(6):776-784.
    View in: PubMed
    Score: 0.016
  5. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020 03; 30(3):269-271.
    View in: PubMed
    Score: 0.016
  6. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 03; 579(7798):270-273.
    View in: PubMed
    Score: 0.016
  7. Bat Severe Acute Respiratory Syndrome-Like Coronavirus WIV1 Encodes an Extra Accessory Protein, ORFX, Involved in Modulation of the Host Immune Response. J Virol. 2016 07 15; 90(14):6573-6582.
    View in: PubMed
    Score: 0.012
  8. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature. 2013 Nov 28; 503(7477):535-8.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.